Patrimony

Parallel convergences: a political economy of drug market access regulation in France and England.

Accès au marché, Bureaucratic politics, Capture, Health technology assessment, Industrie pharmaceutique, Market access, New public management, Nouveau management public, Pharmaceutical industry, Political economy, Politique bureaucratique, Regulation, Regulatory capture, Régulation, State, Économie politique, État, Évaluation des technologies de santé

Essays on quality of care: economic and public health approaches.

Aide à la décision publique, Economie de la santé, Health economics, Health technology assessment, Hospitals, Hôpitaux, Public decision-making, Quality of care, Qualité des soins, Regulation, Régulation, Évaluation des interventions en santé

Ethics and economic evaluation of health interventions for the definition of the scope of reimbursable care.

Adaptation des préférences, Aide à la décision publique, Egalitarisme, Ethics, Ethique, Health technology assessment, Public-decision making, Social choice theory

Dealing with moral dilemma raised by adaptive preferences in health technology assessment: The example of growth hormones and bilateral cochlear implants.

Adaptive preferences, Disability, Health technology assessment, Paediatric treatment, Welfare economics

Ethic and health economic evaluation in the context of decision-making about reimbursement of health technologies by the national health insurance.

Adaptation des préférences, Aide à la décision publique, Egalitarisme, Ethics, Ethique, Health technology assessment, Public-decision making, Social choice theory

Health Technology Assessment: The Scientific Career of a Policy Concept.

Bibliometrics, Health policy, Health technology assessment, History, Network

Health Technology Assessment: The Scientific Career of a Policy Concept.

Bibliometrics, Health policy, Health technology assessment, History, Network

Health economics as a policy tool.

Health Technology Assessment, Économie de la santé

Parallel convergences: a political economy of drug market access regulation in France and England.

Accès au marché, Bureaucratic politics, Capture, Health technology assessment, Industrie pharmaceutique, Market access, New public management, Nouveau management public, Pharmaceutical industry, Political economy, Politique bureaucratique, Regulatory capture, Régulation, State, Économie politique, État, Évaluation des technologies de santé

The Legitimation of Administrative Agencies as Institutional Change : Health Technology Assessment within the French and British Government of Pharmaceuticals.

Administrative agencies, France, Health technology assessment, Legitimation, Parmaceuticals, United Kingdom